• 1
    Murphy DJ, Striate GM. Mortality and morbidity associated with early-onset preeclampsia. Hypertens Pregnancy 2000; 19: 221231.
  • 2
    Sibai B, Dekker G, Kupfermine M. Pre-eclampsia. Lancet 2005; 365: 785799.
  • 3
    Crispi F, Dominguez C, Liurba E, Martin-Gallan P, Cabero L, Gratacos E. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 2006; 195: 201207.
  • 4
    Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195: 4049.
  • 5
    Schlembach D, Wallner W, Sengenberger R, Stiegler E, Mortl M, Beckmann MW. Angiogenic growth factor levels in maternal and fetal blood: Correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2007; 29: 407413.
  • 6
    Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Placental growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to sFlt-1 but not to Flk-1/KDR. J Biol Chem 1994; 269: 2564625654.
  • 7
    Cooper JC, Sharkey AM, McLaren J, Charnock-Jones DS, Smith SK. Location of VEGF and its receptor, sFlt in human placenta and deciduas by immunochemistry. J Reprod Fertil 1995; 105: 205213.
  • 8
    Hauser S, Weich HA. A heparin binding form of placenta growth factor (PLGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 1993; 9: 259268.
  • 9
    Ghosh D, Sharkey AM, Dhawan L, Dhara S, Smith SK. Expression VEGF and PLGF in conceptus and endometrium during implantation in the rhesus monkey. Mol Hum Reprod 2000; 6: 935941.
  • 10
    Levine RJ, Maynard SE, Qian C et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672683.
  • 11
    Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA. Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003; 188: 177182.
  • 12
    Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt-1 (soluble fms-like tyrosine kinase-1) in fetal and maternal serum during preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005; 122: 3339.
  • 13
    Bersinger NA, Odegard RA. Second and third trimester serum levels of placental proteins in preeclampsia and small for gestational age pregnancies. Acta Obstet Gynecol Scand 2004; 83: 3745.
  • 14
    Smith GC, Wear H. The perinatal implications of angiogenic factors. Curr Opin Obstet Gynecol 2009; 21: 111116.
  • 15
    Mishra D, Singh HP. Kuppuswamy's socioeconomic status scale – A revision. Indian J Pediatr 2003; 70: 273274.
  • 16
    Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E. Predictive value of angiogenic factors and uterine artery Doppler for early-versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 31: 303309.
  • 17
    Davey DA, MacGillivray I. The classification and definition of hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892898.
  • 18
    Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements – a prospective study. Am J Obstet Gynecol 1985; 151: 333337.
  • 19
    Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159174.
  • 20
    Rosati P, Bartolozzi F, Guariglia L. Intra- and interobserver repeatability of femur length measurement in early pregnancy. Ultrasound Obstet Gynecol 2004; 23: 599601.
  • 21
    Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308: 15921594.
  • 22
    Pijnenborg R, Robertson WB, Brosens I, Dixon G. Review article: Trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals. Placenta 1981; 2: 7191.
  • 23
    Gerretsen G, Huisjes HJ, Elema JD. Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. BJOG 1981; 88: 876881.
  • 24
    Harman CR, Baschat AA. Comprehensive assessment of fetal wellbeing: Which Doppler tests should be performed? Curr Opin Obstet Gynecol 2003; 15: 147157.
  • 25
    Chappel LC, Seed PT, Briley A et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187: 127136.
  • 26
    Madazli R, Kuseyrioglu B, Uzun H, Uludag S. Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry. Int J Gynaecol Obstet 2005; 89: 251257.
  • 27
    Erez O, Romero R, Espinoza J et al. The change in concentrations of angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent of preeclampsia and SGA. J Matern Fetal Neonatal Med 2008; 21: 279287.
  • 28
    Ghosh SK, Raheja S, Tuli A, Raghunandan C, Agarwal S. Combination of uterine artery Doppler velocimetry and maternal serum placental growth factor estimation in predicting occurrence of preeclampsia in early second trimester pregnancy: A prospective cohort study. Eur J Obstet Gynecol Reprod Biol 2012; 161: 144151.
  • 29
    Espinoza J, Romero R, Nien JK et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007; 196: 326.e1326.13.
  • 30
    Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH. Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. Am J Obstet Gynecol 2006; 195: 16681673.
  • 31
    Sahlin L, Ostlund E, Wang H, Holmgren A, Fried G. Decreased expression of thioredoxin and glutaredoxin in placentae from pregnancies with preeclampsia and intrauterine growth restriction. Placenta 2000; 21: 603609.
  • 32
    Choi SJ, Oh SY, Kim JH, Sadovsky Y, Roh CR. Increased expression of N-myc downstream-regulated gene 1 (NDRG1) in placentas from pregnancies complicated by intrauterine growth restriction or preeclampsia. Am J Obstet Gynecol 2007; 196: e1e7.
  • 33
    Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba'aqeel H. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 2006; 194: 921931.
  • 34
    Burton GJ, Yung HW, Cindrova-Davies T, Charnock- Jones DS. Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 2009; 30 (S): 4348.
  • 35
    Ebrashy A, Ibrahim M, Marzook A, Yousef D. Usefulness of aspirin therapy in high risk pregnant women with abnormal uterine artery Doppler ultrasound at 14–16 weeks pregnancy: Randomized controlled clinical trial. Croat Med J 2005; 46: 826831.
  • 36
    Campbell S, Black RS, Lees CC, Armstrong V, Peacock JL. Doppler ultrasound of the maternal uterine arteries: Disappearance of abnormal waveforms and relation to birthweight and pregnancy outcome. Acta Obstet Gynecol Scand 2000; 79: 631634.
  • 37
    Prefumo F, Guven M, Ganapathy R, Thilaganathan B. The longitudinal variation in uterine artery blood flow pattern in relation to birth weight. Obstet Gynecol 2004; 103: 764768.
  • 38
    Mari G, Hanif F. Intrauterine growth restriction: How to manage and when to deliver. Clin Obstet Gynecol 2007; 50: 497509.